SCHEMBL4596217

SCHEMBL4596217

CC(C)(C)[C@](CO)(CCc1ccccc1)NC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
MAPT P10636 1/20 0.45
SSTR4 P31391 1/20 0.44
POLB P06746 2/20 0.42
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
ALDH1A1 P00352 3/20 0.40
DUT P33316 1/20 0.39
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4073210 0.84 CYP3A4 (0.46) NPC1RAB9AMAPTALDH1A1CYP3A4
SCHEMBL1273081 0.84 CYP3A4 (0.46) NPC1RAB9AMAPTALDH1A1CYP3A4
SCHEMBL567236 0.81 NPC1 (0.47) NPC1RAB9AMAPTSSTR4POLB
SCHEMBL4595848 0.78 CYP2C19 (0.41) NPC1RAB9AMAPTALDH1A1CYP2C19
SCHEMBL4658500 0.78 KDM4E (0.49) NPC1RAB9AMAPTPOLBALDH1A1
SCHEMBL4583207 0.73 CYP3A4 (0.50) NPC1RAB9AMAPTALDH1A1CYP3A4
SCHEMBL1539491 0.73 VNN1 (0.42) RAB9APOLBMEN1KMT2ATAAR1
SCHEMBL4379160 0.73 FDPS (0.46) MAPTALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL3960044 0.73 RIPK1 (0.41) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL16757585 0.72 CYP2C9 (0.44) NPC1RAB9AMAPTPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874768-A2 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2008-01-09 EP disclosed
WO-2006113837-A2 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2006-10-26 WO disclosed